Retraction

Psoriasin (S100A7) is a novel biomarker for lung squamous cell carcinoma in humans

Retraction Details

Retraction Reason:

Duplication of/in Article

Nature of Retraction:

Retraction

Retraction Notice:
10.1186/s12935-016-0316-3

Citations (8)

8
Total Citations
6
Post-Retraction
(75.0%)
1
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
4 After 2+ years
2406 Days since retraction (latest)
Expression Analysis of S100A7 Protein in Cervical Squamous Cell Carcinoma
宏 傅
Advances in Clinical Medicine
Published: Jan 2023
2406 days after retraction
Paper citing Psoriasin (S100A7) is a novel biomarker for lung s...
Unknown Authors
Unknown Journal
Published: Sep 2021
1919 days after retraction
Paper citing Psoriasin (S100A7) is a novel biomarker for lung s...
Unknown Authors
Unknown Journal
Published: Jun 2021
1844 days after retraction
Paper citing Psoriasin (S100A7) is a novel biomarker for lung s...
Unknown Authors
Unknown Journal
Published: Aug 2018
820 days after retraction
Paper citing Psoriasin (S100A7) is a novel biomarker for lung s...
Unknown Authors
Unknown Journal
Published: Nov 2017
531 days after retraction
MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7
Fei Fan, Jiongjiong Lu, Wenlong Yu et al. (7 authors)
Oncology Letters Open Access
Published: Nov 2017
19 citations
520 days after retraction
Paper citing Psoriasin (S100A7) is a novel biomarker for lung s...
Unknown Authors
Unknown Journal
Published: May 2016
Same day as retraction
Paper citing Psoriasin (S100A7) is a novel biomarker for lung s...
Unknown Authors
Unknown Journal
Published: Jan 2016
140 days before retraction
Quick Stats
Total Citations: 8
Years Since Retraction: 9.5 years
Open Access: Yes
Last Checked: Never
Related Papers